APA

Birdwell K. A., Decker B., Barbarino J. M., Peterson J. F., Stein C. M., Sadee W., Wang D., Vinks A. A., He Y., Swen J. J., Leeder J. S., van Schaik R., Thummel K. E., Klein T. E., Caudle K. E. & MacPhee I. A. M. (20150831). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. : Clinical pharmacology and therapeutics.

Chicago

Birdwell K A, Decker B, Barbarino J M, Peterson J F, Stein C M, Sadee W, Wang D, Vinks A A, He Y, Swen J J, Leeder J S, van Schaik Rhn, Thummel K E, Klein T E, Caudle K E and MacPhee I A M. 20150831. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. : Clinical pharmacology and therapeutics.

Harvard

Birdwell K. A., Decker B., Barbarino J. M., Peterson J. F., Stein C. M., Sadee W., Wang D., Vinks A. A., He Y., Swen J. J., Leeder J. S., van Schaik R., Thummel K. E., Klein T. E., Caudle K. E. and MacPhee I. A. M. (20150831). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. : Clinical pharmacology and therapeutics.

MLA

Birdwell K A, Decker B, Barbarino J M, Peterson J F, Stein C M, Sadee W, Wang D, Vinks A A, He Y, Swen J J, Leeder J S, van Schaik Rhn, Thummel K E, Klein T E, Caudle K E and MacPhee I A M. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. : Clinical pharmacology and therapeutics. 20150831.